Royal Bank of Canada (RBC) has announced the launch of Auto-Callable Contingent Coupon Barrier Notes, which are linked to the performance of the Nasdaq-100, Russell 2000, and S&P 500 indices. This offering is significant as it reflects RBC's ongoing efforts to diversify its financial products and cater to a broader range of investors seeking exposure to market performance.
The notes are structured to provide contingent coupons and a potential return of principal at maturity, depending on the performance of the underlying indices. If the notes are not automatically called, investors may receive monthly contingent coupons at a rate of 8.20% per annum, provided the indices meet specific performance thresholds.
Background
Royal Bank of Canada, incorporated in Canada, operates primarily in the commercial banking sector as indicated by its SIC code 6029. The bank trades under the ticker symbols RY on the NYSE and RYLBF on the OTC market. Recent filings include multiple 424B2 forms, reflecting the bank's active engagement in the capital markets.
What the Filing Says
According to the SEC filing (accession number 0000950103-26-017069), the notes are set to be issued on November 19, 2026, with a maturity date of August 21, 2031. The pricing supplement details that the notes will not be listed on any securities exchange, and all payments are subject to the bank's credit risk.
Impact
This new offering may appeal to a range of investors, including those looking for structured products with specific risk profiles. By introducing these notes, RBC aims to enhance its competitive position in the commercial banking industry, where innovative financial products are increasingly important for attracting clients.
What's Next
The filing does not say what happens next.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










